CHIMERIC THERAPEUTICS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.018 AUD | 0.00% |
|
0.00% | -48.57% |
| May. 22 | Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4% | MT |
| May. 20 | Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial | MT |
Evolution of the average Target Price on Chimeric Therapeutics Limited
Price target over the last 5 years
History of analyst recommendation changes
d95281e5e6efe7bf4ee6281b9.uLdjhKh8WEgUOCIbys9n-SYXAfGpwwKQ33lYWC7GEwI.7fg5wdkfYCR9Snpeuf9ejkBuM6Wbmk3jmCw8CHSCdU-OgCjK7zMqEUtQVQ~da9ec53a097835fc2a6018f87a9c5512
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.018
AUD
Average target price
0.15
AUD
Spread / Average Target
+733.33%
High Price Target
0.15
AUD
Spread / Highest target
+733.33%
Low Price Target
0.15
AUD
Spread / Lowest Target
+733.33%
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CHM Stock
- Consensus Chimeric Therapeutics Limited
